Alliancebernstein L.P. Cara Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.65 $3,540 - $9,735	-5,900 Reduced 6.33%	87,320 $64,000
Q2 2023 Aug 15, 2023	BUY	$2.83 - $4.94 $129,670 - $226,350	45,820 Added 96.67%	93,220 $263,000
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $32,572 - $81,730	-6,661 Reduced 12.32%	47,400 $232,000
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $32,332 - $46,495	3,641 Added 7.22%	54,061 $580,000
Q3 2022 Nov 15, 2022	BUY	$8.24 - $12.56 $40,903 - $62,347	4,964 Added 10.92%	50,420 $472,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $938 - $1,743	126 Added 0.28%	45,456 $415,000
Q1 2022 May 13, 2022	BUY	$9.94 - $12.65 $1,073 - $1,366	108 Added 0.24%	45,330 $551,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $116,279 - $175,921	-9,698 Reduced 17.66%	45,222 $551,000
Q3 2021 Nov 10, 2021	SELL	$11.55 - $16.06 $25,063 - $34,850	-2,170 Reduced 3.8%	54,920 $849,000
Q2 2021 Jul 30, 2021	BUY	$12.38 - $29.19 $100,154 - $236,147	8,090 Added 16.51%	57,090 $815,000
Q4 2020 Feb 08, 2021	SELL	$12.72 - $16.16 $161,544 - $205,232	-12,700 Reduced 20.58%	49,000 $741,000
Q3 2020 Nov 12, 2020	SELL	$12.34 - $17.92 $22,212 - $32,256	-1,800 Reduced 2.83%	61,700 $785,000
Q2 2020 Aug 13, 2020	BUY	$12.39 - $17.33 $221,781 - $310,206	17,900 Added 39.25%	63,500 $1.09 Million
Q4 2019 Feb 18, 2020	BUY	$16.11 - $25.98 $33,831 - $54,558	2,100 Added 4.83%	45,600 $735,000
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $1.42 Million - $1.73 Million	-80,390 Reduced 64.89%	43,500 $935,000
Q1 2019 May 14, 2019	SELL	$14.41 - $19.64 $83,578 - $113,912	-5,800 Reduced 4.47%	123,890 $2.43 Million
Q4 2018 Feb 13, 2019	BUY	$12.45 - $23.47 $1.07 Million - $2.02 Million	85,990 Added 196.77%	129,690 $1.69 Million
Q3 2018 Nov 08, 2018	SELL	$17.57 - $23.95 $65,009 - $88,615	-3,700 Reduced 7.81%	43,700 $1.05 Million
Q2 2018 Aug 13, 2018	SELL	$11.6 - $19.27 $73,080 - $121,401	-6,300 Reduced 11.73%	47,400 $908,000
Q1 2018 May 14, 2018	BUY	$11.77 - $16.08 $177,727 - $242,807	15,100 Added 39.12%	53,700 $665,000
Q3 2017 Nov 13, 2017	BUY	$12.6 - $16.34 $486,360 - $630,724	38,600	38,600 $528,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$607,205
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$459,569
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$420,187
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$300,521
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$299,411
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account